No Data
Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts
Achilles Therapeutics Transfers TRACERx Data and MAP Assets to AstraZeneca in $12M Agreement
Express News | Achilles Therapeutics Sells TRACERx And MAP Assets To AstraZeneca For $12M, Transferring Tumor Data And Samples; Concludes Strategic Review With Plans For Workforce And Board Reductions
Press Release: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
London Shares Festive Ahead of Christmas Break; Vistry Slumps on Fresh Profit Warning
AstraZeneca Pulls EU Marketing Application for Lung Cancer Treatment Amid Regulatory Feedback
loading...
Just Care Bears : I thought there’s a FDA approval going on on this today no news yet
Claudius NJIE Just Care Bears : yes good news is coming.
Claudius NJIE : pls run to at least 50